news
API markets to grow 6.8 percent by 2026
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
List view / Grid view
Cancer
news
First PI3K inhibitor for breast cancer approved by FDA
The US Food and Drug Administration (FDA) has approved Piqray (alpelisib) tablets to treat patients with breast cancer.
news
Retail prices on several anti-cancer medications slashed
The retail prices of some anti-cancer drugs have been cut by 87 percent by the drug price control authority in India.
news
Four drug companies accused of illegal market sharing
The CMA accuses four pharmaceutical firms of colluding to illegally inflate prices of an anti-nausea drug.
news
New glioblastoma cancer vaccine shows promise in phase 1b clinical trial
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial...
news
Sales of generic oncology drugs surge
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028...
news
Growing role of personalised and precision medicine in cancer treatments
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
news
Genetically modified viral injection could treat metastatic melanoma
A study has reported that almost 40 percent of patients with non-surgically treatable tumours were effectively treated using a genetically modified virus...
news
Cancer drug with accelerated approval fails Phase III trial
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
news
Clinical trial to develop breath test for cancer launched
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK...
news
Sprayable gel with CD47 blockers could be the future of drug delivery for cancer
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer...
news
Rivaroxaban reduced blood clots and related death in cancer patients
Through a clinical trial, Cleveland researchers have identified how rivaroxaban reduces blood clots in cancer patients and also decreases related deaths...
news
Nanoscale blood test could discover more from cancer patients’ blood
A nanoscale blood test could be used to gain more information from the blood of patients in order to help the identification of cancer in its early stages...
news
Trial results show compound makes radiotherapy more effective
A trial has shown that radiotherapy is more effective when levels of ropidoxuridine in a patients' body reach a certain level...
news
Anti-HER2 drug benefits patients with stomach and bowel cancer
The antibody ZW25 can bind two distinct regions of the HER2 receptor to block the growth of cancer cells and has shown signs of anti-tumour activity...
